Mitomicin Accord 40 mg prašek za raztopino za injiciranje/infundiranje Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mitomicin accord 40 mg prašek za raztopino za injiciranje/infundiranje

accord healthcare - mitomicin - prašek za raztopino za injiciranje/infundiranje - mitomicin 40 mg / 1 viala - mitomicin

Celdoxome pegylated liposomal Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Bivacyn 3.500 i.e./250 i.e. v 1 g mazilo za oko Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bivacyn 3.500 i.e./250 i.e. v 1 g mazilo za oko

lek d.d. - bacitracin; neomicin - mazilo za oko - bacitracin 250 i.e. / 1 g  neomicin3500 i.e. / 1 g; neomicin 3500 i.e. / 1 g - kombinacije različnih antibiotikov